Our lab has shown that birinapant is effective in sensitizing HPV-negative HNSCC to TNFα in vitro, and radiation-induced cytotoxicity in vivo, especially those that harbor FADD/BIRC2 amplifications [16]. The gene discussed is TNF; the disease is head and neck squamous cell carcinoma.